Russell Investments Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,526
| Closed | -$1.44M | – | 4248 |
|
|
2025
Q4 | $1.44M | Sell |
6,526
-109,767
| -94% | -$17.7M | ﹤0.01% | 2038 |
|
|
2025
Q3 | $11.1M | Buy |
+116,293
| New | +$7.42M | 0.01% | 854 |
|
|
2024
Q4 | – | Sell |
-855
| Closed | -$9.19K | – | 3710 |
|
|
2024
Q3 | $9.19K | Hold |
855
| – | – | ﹤0.01% | 3098 |
|
|
2024
Q2 | $10.2K | Hold |
855
| – | – | ﹤0.01% | 3070 |
|
|
2024
Q1 | $15.7K | Hold |
855
| – | – | ﹤0.01% | 2799 |
|
|
2023
Q4 | $13.6K | Hold |
855
| – | – | ﹤0.01% | 2793 |
|
|
2023
Q3 | $16.1K | Hold |
855
| – | – | ﹤0.01% | 2916 |
|
|
2023
Q2 | $19.3K | Hold |
855
| – | – | ﹤0.01% | 2845 |
|
|
2023
Q1 | $21.7K | Hold |
855
| – | – | ﹤0.01% | 2803 |
|
|
2022
Q4 | $12.9K | Hold |
855
| – | – | ﹤0.01% | 2832 |
|
|
2022
Q3 | $10K | Hold |
855
| – | – | ﹤0.01% | 2860 |
|
|
2022
Q2 | $8K | Hold |
855
| – | – | ﹤0.01% | 2851 |
|
|
2022
Q1 | $14K | Hold |
855
| – | – | ﹤0.01% | 2696 |
|
|
2021
Q4 | $21K | Hold |
855
| – | – | ﹤0.01% | 2948 |
|
|
2021
Q3 | $38K | Hold |
855
| – | – | ﹤0.01% | 2959 |
|
|
2021
Q2 | $34K | Hold |
855
| – | – | ﹤0.01% | 3160 |
|
|
2021
Q1 | $45K | Buy |
+855
| New | +$42.2K | ﹤0.01% | 3041 |
|
|
2020
Q2 | – | Sell |
-3,084
| Closed | -$151K | – | 3134 |
|
|
2020
Q1 | $151K | Buy |
3,084
+2,618
| +562% | +$157K | ﹤0.01% | 2621 |
|
|
2019
Q4 | $34K | Buy |
+466
| New | +$21.3K | ﹤0.01% | 3014 |
|
|
2018
Q4 | – | Sell |
-380
| Closed | -$33K | – | 2926 |
|
|
2018
Q3 | $33K | Sell |
380
-15
| -4% | -$1.32K | ﹤0.01% | 2874 |
|
|
2018
Q2 | $41K | Sell |
395
-740
| -65% | -$69.9K | ﹤0.01% | 2831 |
|
|
2018
Q1 | $91K | Hold |
1,135
| – | – | ﹤0.01% | 2762 |
|
|
2017
Q4 | $157K | Buy |
1,135
+705
| +164% | +$107K | ﹤0.01% | 2709 |
|
|
2017
Q3 | $70K | Hold |
430
| – | – | ﹤0.01% | 2815 |
|
|
2017
Q2 | $65K | Buy |
+430
| New | +$59.4K | ﹤0.01% | 2856 |
|
|
2017
Q1 | – | Sell |
-805
| Closed | -$173K | – | 2995 |
|
|
2016
Q4 | $173K | Buy |
+805
| New | +$167K | ﹤0.01% | 2742 |
|
Russell Investments Group's CDTX Position: Q1 2026 in Review
Russell Investments Group sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 6,526 shares — an estimated $1.44M sold.
Russell Investments Group first reported a position in CDTX in Q4 2016 and held it in 26 quarters. The position peaked at $11.1M in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.
- Russell Investments Group reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
- Russell Investments Group sold 6,526 Cidara Therapeutics shares in Q1 2026, an estimated $1.44M.
- Russell Investments Group first reported a position in Cidara Therapeutics in Q4 2016 and held it in 26 quarters.
- Russell Investments Group's Cidara Therapeutics position peaked at $11.1M in Q3 2025.
- 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.